The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
Development services for gene and cell therapies is planned to begin first in 2025
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Subscribe To Our Newsletter & Stay Updated
